Jeremy Grantham's GMED Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 420,222 shares of Globus Medical, Inc. (GMED) worth $36.69 M, representing 0.09% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in GMED, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 760,108 shares. Largest reduction occurred in Q2 2023, reducing 341,887 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -308,216 | Reduce 42.31% | 420,222 | $87.31 |
| Q3 2025 | +6,657 | Add 0.92% | 728,438 | $57.27 |
| Q2 2025 | +132,504 | Add 22.49% | 721,781 | $59.02 |
| Q1 2025 | +88,793 | Add 17.74% | 589,277 | $73.20 |
| Q4 2024 | -172,994 | Reduce 25.69% | 500,484 | $82.71 |
| Q3 2024 | +87,411 | Add 14.91% | 673,478 | $71.54 |
| Q2 2024 | -79,986 | Reduce 12.01% | 586,067 | $68.49 |
| Q1 2024 | +291,448 | Add 77.80% | 666,053 | $53.64 |
| Q4 2023 | -187,838 | Reduce 33.40% | 374,605 | $53.29 |
| Q3 2023 | +12,304 | Add 2.24% | 562,443 | $49.65 |
| Q2 2023 | -341,887 | Reduce 38.33% | 550,139 | $59.54 |
| Q1 2023 | +760,108 | Add 576.20% | 892,026 | $56.64 |
| Q4 2022 | -25,132 | Reduce 16.00% | 131,918 | $74.27 |
| Q3 2022 | +157,050 | New Buy | 157,050 | $59.57 |
Jeremy Grantham's Globus Medical Investment FAQs
Jeremy Grantham first purchased Globus Medical, Inc. (GMED) in Q3 2022, acquiring 157,050 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Globus Medical, Inc. (GMED) for 14 quarters since Q3 2022.
Jeremy Grantham's largest addition to Globus Medical, Inc. (GMED) was in Q1 2023, adding 892,026 shares worth $50.52 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 420,222 shares of Globus Medical, Inc. (GMED), valued at approximately $36.69 M.
As of the Q4 2025 filing, Globus Medical, Inc. (GMED) represents approximately 0.09% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Globus Medical, Inc. (GMED) was 892,026 shares, as reported at the end of Q1 2023.